Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00547066
Recruitment Status : Unknown
Verified March 2016 by Immunomedics, Inc..
Recruitment status was:  Active, not recruiting
First Posted : October 19, 2007
Last Update Posted : March 21, 2016
Information provided by (Responsible Party):
Immunomedics, Inc.